Sir,

A 74-year-old man presented with anorexia, general fatigue, weight loss and purpura on the lower legs. Auscultation revealed trivial fine crackle. The white blood cell count was 5600/mm^3^, with 6.0% eosinophils. Haemoglobin was 8.5 g/dl. The C-reactive protein was 5.2 mg/dl. BUN, creatinine and uric acid were 11, 0.86 and 5.9 mg/dl, respectively. Liver enzymes were within normal limits. IgG, IgA and IgM were 6170 mg/dl, 129 mg/dl and 38 mg/ dl, respectively. IgG1, IgG2, IgG3 and IgG4 were 3470, 1460, 552 and 807 mg/dl. IgE was 1070 IU/ml. Proteinuria was 100 mg/dl (0.7 g/day), and trivial microhaematuria was observed. NAG was 23.1 U/g·Crn. CH50, C3 and C4 were \<6.3 CH50/ml, 19.2 mg/dl and \<2.0 mg/dl, respectively. C1q was 36.0 μg/ml. The antinuclear antibody was 1280×. Rheumatoid factor and anti-cardiolipin β2 glycoprotein-I antibody were positive. Other serological tests, including ANCA, anti-ds-DNA antibody, anti-Sm antibody and anti-RNP antibody, were all negative. Enhanced computed tomography (enhanced CT) detected interstitial pneumonia and abdominal aortic aneurysm (AAA) with a wall thickness measuring 3.2 × 3.0 cm (Figure [1](#F1){ref-type="fig"}A). ^18^F-fluorodeoxyglucose positron emission tomography-CT (^18^F-FDG PET/CT) demonstrated increased fluorodeoxyglucose activity in the thicken wall of AAA (Figure [1](#F1){ref-type="fig"}B). A renal biopsy specimen showed interstitial nephritis with patchy pattern infiltration of plasma cells (Figure [1](#F1){ref-type="fig"}C). Immunostaining of anti-IgG4 antibodies detected that a lot of IgG4-positive plasma cells infiltrated into the interstitium, compatible with IgG4-positive multi-organ lymphoproliferative syndrome (IgG4^+^MOLPS) (Figure [1](#F1){ref-type="fig"}D). He was treated with prednisolone (PSL) 40 mg daily. His clinical manifestations, laboratory data and imaging tests were all improved within 2 weeks.

![Findings of enhanced CT, ^18^F-FDG PET/CT and renal biopsy. (**A**) Enhanced CT reveals wall thickness of abdominal aorta, compatible with IAAA (arrow). (**B**) PET-CT detects FDG uptake within thicken aortic wall, compatible with IAAA (arrow). (**C**) Light microscopic findings of a renal biopsy specimen. Patchy patterns of plasma cells infiltrations are observed in the interstitium. PAS stain. 200×. (**D**) Immunostaining of anti-IgG4 antibodies detected many IgG4^+^plasma cells in the interstitium.](sfp170fig1){#F1}

IgG4^+^MOLPS is a new clinical entity, characterized by hyper-IgG4 gamma-globulinaemia, IgG4^+^ plasma cell infiltration in involved tissue with a favourable response to steroids, and includes Mikulicz\'s disease, autoimmune pancreatitis (AIP), retroperitoneal and mediastinal fibrosis, interstitial nephritis and many other inflammatory conditions affecting multiple organs \[[@R1]\]. Though AAA is the most common type of aneurysm, IAAA is a rare variant of AAA, which is seen in 5-- 10% of all cases of AAA \[[@R2]\]. IAAA has some similarities to retroperitoneal fibrosis and had been previously considered to be one member of chronic periaortitis as well as idiopathic retroperitoneal fibrosis. Recently, IgG4^+^ IAAA has been proposed to be estimated as 'IgG4-related periaortitis' together with retroperitoneal fibrosis \[[@R3]\]. ^18^F-FDG uptake is caused by increased glucose utilization, observed not only in malignant cells but also in inflammatory tissue \[[@R4]\]. ^18^F-FDG PET/CT has been recently reported as being useful to diagnose and follow-up AIP and associated extrapancreatic lesions \[[@R4]\]. In the present case, steroid therapy could improve immediately the clinical manifestations of IgG4^+^MOLPS, such as interstitial nephritis, interstitial pneumonia and IAAA. ^18^F-FDG PET/CT is useful for monitoring both the disease activity of IgG4^+^MOLPS and the effect of steroid therapy.
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